CoChat

GABA interneurons mediate the rapid antidepressant-like effects of scopolamine

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Major depressive disorder (MDD) is a recurring psychiatric illness that causes substantial health and socioeconomic burdens. Clinical reports have revealed that scopolamine, a nonselective muscarinic acetylcholine receptor antagonist, produces rapid antidepressant effects in individuals with MDD. Preclinical models suggest that these rapid antidepressant effects can be recapitulated with blockade of M1-type muscarinic acetylcholine receptors (M1-AChR); however, the cellular mechanisms underlying activity-dependent synaptic and behavioral responses to scopolamine have not been determined. Here, we demonstrate that the antidepressant-like effects of scopolamine are mediated by GABA interneurons in the medial prefrontal cortex (mPFC). Both GABAergic (GAD67+) interneurons and glutamatergic (CaMKII+) interneurons in the mPFC expressed M1-AChR. In mice, viral-mediated knockdown of M1-AChR specifically in GABAergic neurons, but not glutamatergic neurons, in the mPFC attenuated the antidepressant-like effects of scopolamine. Immunohistology and electrophysiology showed that somatostatin (SST) interneurons in the mPFC express M1-AChR at higher levels than parvalbumin interneurons. Moreover, knockdown of M1-AChR in SST interneurons in the mPFC demonstrated that M1-AChR expression in these neurons is required for the rapid antidepressant-like effects of scopolamine. These data indicate that SST interneurons in the mPFC are a promising pharmacological target for developing rapid-acting antidepressant therapies.

Overview

Integrity signals

Registry

Crossref · 10.1172/jci85033

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 1

  1. 10.1038/npp.20 · doi:10.1038/npp.20

Cited by

Items 101–144 of 144

Metadata

Authors
Wohleb, E. S., Wu, M., Gerhard, D. M., Taylor, S. R., Picciotto, M. R., Alreja, M., & Duman, R. S.
Affiliations
Yale University (US)
Corresponding author
Duman, Ronald S.
Venue
Journal of Clinical Investigation
Published
2016-06-06
Volume
126
Issue
7
Pages
2482-2494
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2415443438
Cited by
144
References
56
Citations by year
2026: 8 · 2025: 7 · 2024: 10 · 2023: 16 · 2022: 12 · 2021: 14 · 2020: 25 · 2019: 20 · 2018: 17 · 2017: 14 · 2016: 1
FWCI
14.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Yale University
  • National Institutes of Health (UL1TR001863)
  • National Institute of Mental Health (R01MH093897, R37MH045481, R01MH045481, R01MH077681, R01MH105910)
  • National Institute of General Medical Sciences (T32GM007324)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
scopolamine, rapid antidepressant effects, major depressive disorder, M1 muscarinic receptor, GABAergic interneurons, somatostatin interneurons, parvalbumin interneurons, medial prefrontal cortex, muscarinic receptor blockade, antidepressant targets
MeSH terms
Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Major Depressive Disorder, Electrophysiology, Female, Humans, Interneurons, Male, Mice, Inbred C57BL, Mice, Transgenic, Scopolamine, Prefrontal Cortex, Mice, GABAergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.